Timothy J. Ives

2.2k total citations
68 papers, 1.6k citations indexed

About

Timothy J. Ives is a scholar working on Geriatrics and Gerontology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Timothy J. Ives has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Geriatrics and Gerontology, 16 papers in Pharmacology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Timothy J. Ives's work include Pharmaceutical Practices and Patient Outcomes (20 papers), Opioid Use Disorder Treatment (9 papers) and Pain Management and Opioid Use (7 papers). Timothy J. Ives is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (20 papers), Opioid Use Disorder Treatment (9 papers) and Pain Management and Opioid Use (7 papers). Timothy J. Ives collaborates with scholars based in United States. Timothy J. Ives's co-authors include Paul R. Chelminski, Michael Pignone, R. C. Malone, Darren A. DeWalt, J. Stephen Perhac, Betsy Bryant Shilliday, Catherine A. Hammett‐Stabler, Nicholas M. Potisek, John D. Butts and Philip D. Sloane and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Timothy J. Ives

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy J. Ives United States 20 598 421 329 289 287 68 1.6k
Mark Bounthavong United States 22 501 0.8× 362 0.9× 99 0.3× 114 0.4× 512 1.8× 94 1.8k
Scott G. Weiner United States 26 1.4k 2.3× 250 0.6× 416 1.3× 111 0.4× 245 0.9× 172 2.7k
Laura Anderson United States 15 269 0.4× 246 0.6× 153 0.5× 80 0.3× 159 0.6× 19 1.2k
Paul D. van der Linden Netherlands 21 251 0.4× 151 0.4× 87 0.3× 446 1.5× 287 1.0× 56 2.2k
Tony Antoniou Canada 28 694 1.2× 158 0.4× 275 0.8× 270 0.9× 359 1.3× 154 3.1k
Cindy Parks Thomas United States 23 961 1.6× 183 0.4× 153 0.5× 135 0.5× 428 1.5× 62 1.9k
Kirsha S. Gordon United States 24 480 0.8× 116 0.3× 135 0.4× 177 0.6× 258 0.9× 86 2.1k
Tania Shelby‐James Australia 16 800 1.3× 184 0.4× 60 0.2× 49 0.2× 381 1.3× 39 1.6k
Eric I. Rosenberg United States 15 250 0.4× 103 0.2× 176 0.5× 141 0.5× 95 0.3× 44 1.1k
Jeffrey Bratberg United States 22 1.0k 1.7× 377 0.9× 236 0.7× 34 0.1× 219 0.8× 97 1.5k

Countries citing papers authored by Timothy J. Ives

Since Specialization
Citations

This map shows the geographic impact of Timothy J. Ives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Ives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Ives more than expected).

Fields of papers citing papers by Timothy J. Ives

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Ives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Ives. The network helps show where Timothy J. Ives may publish in the future.

Co-authorship network of co-authors of Timothy J. Ives

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Ives. A scholar is included among the top collaborators of Timothy J. Ives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Ives. Timothy J. Ives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
McLaughlin, Jacqueline E., et al.. (2022). Increasing access to the profession: Admissions lessons learned from the pandemic. Currents in Pharmacy Teaching and Learning. 14(10). 1305–1308. 4 indexed citations
3.
Maierhofer, Courtney, Shabbar I. Ranapurwala, Bethany L. DiPrete, et al.. (2021). Association Between Statewide Opioid Prescribing Interventions and Opioid Prescribing Patterns in North Carolina, 2006–2018. Pain Medicine. 22(12). 2931–2940. 11 indexed citations
4.
Urick, Benjamin Y., et al.. (2019). Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study. Research in Social and Administrative Pharmacy. 15(8). 1027–1031. 10 indexed citations
6.
Hale, Jonathan C., Matthew M. Murawski, & Timothy J. Ives. (2015). Practice Characteristics and Geographic Distribution of Clinical Pharmacist Practitioners in North Carolina. North Carolina Medical Journal. 76(4). 205–210. 7 indexed citations
7.
Adams, Alex J., Gary E. DeLander, George E. MacKinnon, et al.. (2013). Report of the AACP Task Force on Patient-Centered Medical Homes and Accountable Care Organizations. American Journal of Pharmaceutical Education. 77(7). 142–142. 15 indexed citations
8.
Ives, Timothy J., Paul R. Chelminski, Catherine A. Hammett‐Stabler, et al.. (2006). Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Services Research. 6(1). 46–46. 371 indexed citations
9.
Hall, Iris H., et al.. (2003). Effects of alatrofloxacin, the parental prodrug of trovafloxacin, on phagocytic, anti-inflammatory and immunomodulation events of human THP-1 monocytes. Biomedicine & Pharmacotherapy. 57(8). 359–365. 9 indexed citations
10.
11.
Hall, Iris H., et al.. (2003). Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions. International Journal of Antimicrobial Agents. 22(6). 579–587. 9 indexed citations
12.
Ives, Timothy J., et al.. (2003). In-vitro anti-inflammatory and immunomodulatory effects of grepafloxacin in zymogen A- or Staphylococcus aureus-stimulated human THP-1 monocytes. Journal of Infection and Chemotherapy. 9(2). 134–143. 11 indexed citations
13.
Hall, Iris H., et al.. (2002). Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes. International Journal of Antimicrobial Agents. 20(5). 348–360. 18 indexed citations
14.
15.
Ives, Timothy J., et al.. (1998). Integration of Medicinal Chemistry and Pharmacotherapeutics Courses: A Case-Based, Learner-Centered Approach. American Journal of Pharmaceutical Education. 62(4). 406–411. 6 indexed citations
16.
Ives, Timothy J.. (1992). Benzoyl Peroxide. American Pharmacy. 32(8). 33–38. 8 indexed citations
17.
Ives, Timothy J.. (1992). Dermatologic adverse drug reactions in a family medicine setting. Archives of Family Medicine. 1(2). 241–245. 16 indexed citations
18.
Baldwin, Jeffrey N., Kim E. Light, Christopher Stock, et al.. (1991). Curricular Guidelines for Pharmacy Education: Substance Abuse and Addictive Disease. American Journal of Pharmaceutical Education. 55(4). 311–316. 17 indexed citations
19.
Ives, Timothy J. & Ronald B. Stewart. (1980). Doxepin-induced acute glossitis. American Journal of Health-System Pharmacy. 37(11). 1551–1552. 3 indexed citations
20.
Ives, Timothy J., et al.. (1980). Effect of Methyldopa on Urine Glucose Test Methods. American Journal of Health-System Pharmacy. 37(5). 683–687. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026